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Background: Identifying permissible limits of intracellular parameters such as protein expression provides
important information for examining robustness. In this study, we used the TEV protease-mediated induction of
protein instability (TIPI) in combination with the genetic Tug-of-War (gTOW) to develop a method to measure the
lower limit of protein level. We first tested the feasibility of this method using ADE2 as a marker and then analyzed
some cell cycle regulators to reveal genetic interactions.
Results: Using TIPI-gTOW, we successfully constructed a strain in which GFP-TDegFAde2 was expressed at the lower
limit, just sufficient to support cellular growth under the −Ade condition by accelerating degradation by TEV protease.
We also succeeded in constructing a strain in which the minimal level of GFP-TDegFCdc20 was expressed by TIPI-gTOW.
Using this strain, we studied genetic interactions between cell cycle regulators and CDC20, and the result was highly
consistent with the previously identified interactions. Comparison of the experimental data with predictions of a
mathematical model revealed some interactions that were not implemented into the current model.
Conclusions: TIPI-gTOW is useful for estimating changes in the lower limit of a protein under different conditions,
such as different genetic backgrounds and environments. TIPI-gTOW is also useful for analyzing genetic interactions
of essential genes whose deletion mutants cannot be obtained.Background
Effective functioning of cellular systems requires optimal
expression of individual proteins [1-3]. On the other
hand, cellular systems are generally robust against
changes in protein expression [4-6]. Identifying permis-
sible limits of intracellular parameters such as protein
expression provides important information for examin-
ing robustness [4-6].
We previously developed a method designated genetic
Tug-Of-War (gTOW), by which we can measure the
limit of overexpression of a target protein [7,8]. In
gTOW, we clone a target gene with its native promoter
into a 2 μ-based plasmid harboring leu2d. Under
leucine-lacking (−Leu) conditions, the copy number of
the plasmid reaches >100 copies because of the selection
bias driven by leu2d. If the target protein expression* Correspondence: hisaom@cc.okayama-u.ac.jp
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reproduction in any medium, provided the orreaches the upper limit, i.e., essential cellular functions
come to a halt when the level of protein exceeds a cer-
tain limit, the gene/plasmid copy number must decrease
to below the upper limit. In gTOW, we thus increase
the expression of a protein to a limit by increasing the
copy number and then determine the upper limit by
measuring the corresponding copy number of the gene.
Using gTOW, we previously measured the copy number
limits for overexpression of 30 cell cycle regulatory
genes in the budding yeast Saccharomyces cerevisiae and
studied the robustness of the cell cycle and mechanisms
that can improve the robustness of the cell cycle
[7,9,10]. We recently measured the copy number limits
of all yeast genes and showed that the yeast cellular sys-
tem is robust against >100-fold increase in the copy
numbers of each of >80% genes [11]. In that analysis, we
also identified 115 “dosage-sensitive genes” whose copy
number limits were <10 [11].
While gTOW is a method to measure the upper limit
of protein expression, determination of the lower limit isLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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periments reduce the expression of a target protein to 0.
Gene-deletion experiments for all genes in S. cerevisiae
have revealed that about 20% genes are essential for cel-
lular growth under normal conditions [12]; other genes
are essential for cellular growth under specific condi-
tions such as specific environmental conditions or in
combination with other gene knockouts [13,14]. Each of
these proteins must have a minimal requirement level
(i.e., the lower limit) to support cellular growth under
each of these conditions. At present, there is no effective
method to assess the lower expression limit of a target
protein.
To assess the lower limit, we have to gradually reduce
the expression of a protein and then measure the lower
limit by some methods. To reduce the expression of a
gene/protein, we need to reduce the production rate of
the transcript, increase the degradation rate of the tran-
script, decrease the production rate of the protein, or in-
crease the degradation rate of the protein. To identify
the lower limit of expression, we would need to specific-
ally decrease/increase the production/degradation rate of
the target and evaluate the limit that would halt cellular
function. Experimental methods that could potentially
be used for this purpose in S. cerevisiae are as follows:
(1) decreasing the expression rate of the transcript using
a repressible promoter [15], (2) decreasing the transcrip-
tion rate or increasing the degradation rate using RNA
interference (RNAi) [16], (3) increasing the degradation
of mRNA by the decreased abundance by mRNA per-
turbation (DAmP) method [17,18], (4) increasing the
rate of degradation of the transcript by recruiting the
RNA-degrading enzyme to the 3′ region of the tran-
script [19], (5) increasing the rate of degradation of the
protein using inducible degrons [20,21], (6) increasing
the rate of degradation of the protein using the TEV
protease-mediated induction of protein instability (TIPI)
method [22,23].
In this study, we used TIPI in combination with
gTOW to develop a method to measure the lower limit
of protein expression. In TIPI, a target protein is
expressed with a TEV protease-induced degron, an
N-terminal sequence containing a cleavage site for the
site-specific TEV protease. Cleavage of the protein at
this site by the TEV protease triggers the exposure of
the “N-degron” [24], which triggers the rapid degrad-
ation of the target protein through the N-end rule path-
way. We chose TIPI because, theoretically, we can
increase the degradation rate of the target protein by in-
creasing the expression of TEV protease using the
gTOW scheme with a plasmid encoding TEV. We can
then evaluate the lower limit of the target protein ex-
pression by measuring the copy number of the TEV
plasmid. We first tested the feasibility of this methodusing ADE2 as a marker and then analyzed some cell
cycle regulators to reveal genetic interactions.
Results and discussion
Establishment of TIPI-gTOW using ADE2 as a marker
In the gTOW method, we cloned the target gene into a
plasmid and increased the copy number using the gen-
etic bias for leu2d [7,8]. In this study, by increasing the
copy number of the gene encoding TEV protease using
the gTOW scheme, we attempted to increase the deg-
radation rate of a target protein containing a TEV
protease-induced degron (Figure 1). If the target protein
expression is at the lower limit for any essential cellular
function, the degradation rate must be less than that re-
quired to maintain the lower limit, which will restrict
the upper limit copy number of the gene encoding TEV.
We designated this scheme TIPI-gTOW.
To ensure the success of this approach, we need to ad-
just the expression of the following: (1) the target pro-
tein (determined by the production and degradation
rate) to be in the range required to support the growth
of the cell (not too high and not too low) and (2) the
TEV protease to be in the appropriate range to induce
degradation in order to detect the lower limit of the tar-
get protein expression. Taxis et al. used the CYC1 pro-
moter and ADH1 promoter to express target proteins
and the GAL1 promoter to induce TEV protease expres-
sion [22,23]. In some cases, they could not observe ex-
pected lethal phenotypes, probably because the induced
degradation of the target proteins by the TEV protease
was insufficient to reduce the protein expression to their
lower limits [22,23].
We used constitutive promoters to increase the ex-
pression of TEV protease in accordance with the in-
crease in gene copy number. We first used the S.
cerevisiae TEF1 promoter to express TEV protease, but
the strong expression of TEV protease from the TEF1
promoter on the high-copy gTOW plasmid in itself
caused a cellular growth defect (data not shown). We
currently do no know what causes this toxicity. We then
used the CUP1 promoter. In the culture conditions we
used (0.25 μM Cu2+), the CUP1 mRNA level was about
10% of the TEF1 mRNA level (data not shown). Expres-
sion of the TEV protease from the CUP1 promoter did
not show any cellular growth defect, even when the gene
copy number exceeded 100 (data not shown). We used
an efficient version of the p14–TEV fusion protein
(p14*–TEV+) [22,23]; here, we designated this “pTEV+.”
We also designated the gTOW plasmid encoding the
pTEV+ expressed from the CUP1 promoter as the “TEV
plasmid.”
To test the feasibility of TIPI-gTOW, we selected
ADE2 as a target. ADE2 encode phosphoribosylaminoi-
midazole carboxylase, an enzyme involved in the adenine
Figure 1 Scheme of TIPI-gTOW. We first constructed a strain in which the chromosomal target gene was replaced by a GFP-TDegFtarget
construct. We next introduced the TEV plasmid, a plasmid for gTOW that encodes pTEV+ expressed from the CUP1 promoter. According to the
TIPI procedure, cleavage and rapid degradation of the GFP-TDegFtarget is induced by pTEV+. Using the gTOW procedure, in which the copy
number of the TEV plasmid exceeds 100 under the −Leu condition, we can increase the expression of pTEV+, which accelerates the degradation
of the GFP-TDegFtarget, reducing the level of the GFP-TDegFtarget. It is thus expected that the upper limit copy number of the TEV plasmid would
inversely correlate with the lower limit of the GFP-TDegFtarget. The tug-of-war between the bias to increase the copy number of leu2d and the
bias to decrease the copy number of pTEV+ gene determines the plasmid copy number in the cell under the −Leu condition. It is thus possible
to indirectly estimate the lower limit of the GFP-TDegFtarget by measuring the copy number of the TEV plasmid.
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monitored by assessing cellular growth defect and by ac-
cumulation of red pigment in the absence of adenine
[25]. We integrated ADE2 with the TEV-induced degron
expressed from the CDC19 promoter into the chromo-
somal ADE2 locus (Figure 1). We chose the TDegF
degron because it is one of the strongest degrons
[22,23]. We then introduced the TEV plasmid into the
cell. The results of TIPI-gTOW experiments of ADE2
are shown in Figure 2. Cellular growth deficiency and
red colony formation were observed for cells containing
the TEV plasmid in the −Leu−Ade condition (Figure 2A).
We note that colonies are expected to be redder on
SC–Ura–Leu plates than the ones on SC–Ura plates,
but they were not (Figure 2A). We currently do not
know the reason. Unknown interaction between the
leucine deficiency and the red color formation might
exist. We next measured the copy numbers of the
TEV plasmid and found that the copy number limit
of the TEV plasmid decreased significantly under
the −Leu−Ade condition (Figure 2B). We thus en-
sured that the Ade2 protein was expressed at the
lower limit and indirectly estimated the lower limit
from the TEV plasmid copy number. We note that
the copy numbers of the vector were significantly dif-
ferent in between –Ura–Leu and –Ura–Leu–Ade condi-
tions (p < 0.01, Student’s t-test). The replication and/
or partition of the 2 μ-based plasmid might be affected by
the growth conditions.TIPI-gTOW experiments of cell cycle regulators
We next selected 3 essential cell cycle regulators as tar-
get genes to test if TIPI-gTOW was a feasible approach
to assess their lower limits. We constructed the GFP-
TDegF constructs for CDC15, CDC20, and CDC28 and
integrated these into their chromosomal loci. At first, we
used the full-length CDC19 promoter (729 bp) to ex-
press the cell cycle proteins but could not obtain a
CDC20 construct, probably because strong expression of
CDC20 is toxic [26]. We then constructed a series of de-
letions of the CDC19 promoter to reduce its expression
(Additional file 1: Figure S1). The GFP expression from
promoters with a length of 500 bp or less was markedly
lower than that from promoters exceeding 500 bp
(Additional file 1: Figures S1B and S1C). This reduction
might be due to the deletion of a Tye7 binding site located
at −523 bp to −516 bp (Additional file 1: Figure S1A). We
thus used the full-length CDC19 promoter (729 bp), the
CDC19−600 promoter (600 bp), and the CDC19−500 pro-
moter (500 bp) to construct the GFP-TDegF target.
The results of the constructions are summarized in
Additional file 1: Table S1. GFP-TDegFCDC15 constructs
with all 3 promoters were obtained. We observed reduc-
tion in the copy number of the TEV plasmid with the
CDC19−500 promoter construct, but this was not signifi-
cant (Figure 3A, p > 0.01, Student’s t-test). The lower
limit of Cdc15 may be lower than that produced by
TIPI-gTOW. As described above, we could not obtain a
GFP-TDegFCDC20 construct with the full-length CDC19
Figure 2 Evaluation of the lower limit of Ade2 using TIPI-gTOW. (A) Growth of the cells harboring GFP-TDegFADE2 (YSM001) with the vector
and the TEV plasmid on SC plates without the indicated amino acids. Six independent colonies of each strain were tested. (B) Copy numbers of
the plasmids of GFP-TDegFADE2 (YSM001) in SC medium without the indicated amino acids. Four independent measurements were performed,
and the average is shown. The error bar indicates the standard deviation. *: p < 0.01 for Student’s t-test.
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the expression was too high. However, we obtained a
GFP-TDegFCDC20 integrated strain with the CDC19−500
promoter. With this strain, we succeeded to detect sig-
nificant restriction of the copy numbers of the TEV plas-
mid under both −Ura and −Ura−Leu conditions
(Figure 3B, p < 0.01, Student’s t-test). We obtained GFP-
TDegFCDC28 integrated strains with all the 3 promoters
and observed significant restrictions of the copy number
of the TEV plasmid with the CDC19−600 promoter under
the −Ura − Leu condition (Figure 3C, p < 0.01, Student’s
t-test). We did obtain a GFP-TDegFCDC28 integrated
strain with the CDC19−500 promoter but could not ob-
tain any transformants with the TEV plasmid, probably
because the expression of Cdc28 from the CDC19−500
promoter was already close to the lower limit of Cdc28,
even in the absence of TEV protease.
Reduction in the protein expression of GFP-TDegFCdc28
by TEV protease was confirmed by western blotting with
anti-GFP antibody (Figure 3D). The GFP-TDegFCdc28 pro-
tein expressed from the CDC19−500 promoter seemed to
be too low to be detected by western blotting (Figure 3D).
Simultaneously, we could not detect any GFP-TDegFCdc20
protein expressed from the CDC19-500 promoter (data
not shown).We further analyzed the TEV protease dependent
cleavage and reduction of GFP-TDegFCdc28 by western
blotting with anti-Cdc28 antibody (Figure 3E). The
protein levels of GFP-TDegFCdc28 in YSM005 (P_CDC-
19−600-GFP-
TDegFCDC28) were highly reduced in the
presence of the TEV plasmid compared with the vector
control, and the level was lower under the –Ura–Leu
condition, where the expression of pTEV+ increased,
than the –Ura condition. Cleaved products (degFCdc28)
were also observed in the presence of the TEV plasmid.
The summed levels of the GFP-TDegFCdc28 and
degFCdc28 were comparable with the Cdc28 levels
expressed in BY4741 (wild type). These results con-
firmed that the target protein level was actually reduced
using TIPI-gTOW. We also tired to detect Cdc20 by
western blotting using anti-Cdc20 antibodies (sc-6730
and sc-6731, Santa Cruz biotechnology). However, we
could not detect any signal, probably because the ex-
pression level of Cdc20 is too low to detect with these
antibodies.
Estimation of changes in the lower limit of CDC20 in
gene-deletion strains
As described above, we identified conditions under
which the GFP-TDegFCdc20 expression was reduced to
Figure 3 TIPI-gTOW experiments of the cell cycle regulators. Copy numbers of the plasmids in the strain; (A) P_CDC19−500-GFP-
TdegFCDC15
(YSM002), (B) P_CDC19−500-GFP-
TdegFCDC20 (YSM003), and (C) P_CDC19−600-GFP-
TdegFCDC28 (YSM005) in SC medium without the indicated amino
acids. Four independent measurements were performed, and the average is shown. The error bar indicates the standard deviation. *: p < 0.01 for
Student’s t-test. (D) Western blotting for GFP-TdegFCdc28 protein in strains YSM005 (P_CDC19−600) and YSM004 (P_CDC19−500) expressed in SC
medium without the indicated amino acids, as detected with anti-GFP antibody. (E) Western blotting for GFP-TdegFCdc28 protein and pTEV+ in
strains BY4741 (wild type) and YSM005 (P_CDC19−600-GFP-
TdegFCDC28) expressed in SC medium without the indicated amino acids, as detected
with anti-Cdc28 antibody (upper blot) and anti-TEV protease antibody (middle blot). In D and E; Coomassie® G-250 staining of 50 kDa bands
(corresponding to the size of EF-1α) are shown as loading controls. “–U” and “–UL” indicate –Ura and –Ura–Leu, respectively.
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limits of GFP-TDegCdc20 in gene-deletion strains using
TIPI-gTOW. We integrated the P_CDC19−500-GFP-
TDegFCdc20 construct into the chromosomal CDC20
locus of each of 23 cell cycle regulator deletion strains
and measured the TEV plasmid copy number. The copy
number data is shown in Table 1. We first noticed that
the copy numbers of the vector itself varied among dele-
tion strains. This may be because of differences in the
growth rate or the efficiency of replication and partition-
ing of the plasmid among the deletion strains.
In addition, we observed significant correlations in the
copy numbers of the vector and the TEV plasmid underboth −Ura (r = 0.61) and −Ura−Leu (r = 7.0) conditions
(Additional file 1: Figure S2). We thus considered that it
was not appropriate to simply estimate the lower limit of
GFP-TDegFCdc20 from the copy number of the TEV plas-
mid in each deletion strain. Therefore, we calculated the
ratio of the copy number of the TEV plasmid to that of
the vector in each deletion strain and compared the ratio
with that of the wild type to estimate the relative change
in TEV plasmid copy number (see Methods for details).
Figure 4A and Table 1 show the relative copy number
change in each deletion strain. Some strains, such as
cln1Δ, sic1Δ, and cdh1Δ, had negative relative copy
number change values, which indicated that the copy
Table 1 Copy numbers of the vector and the TEV plasmid in CDC20 TIPI-gTOW in the gene-deletion strains
Vector copy number* TEV plasmid copy number* TEV/
vector ratio
Relative change
in copy numberAverage SD Average SD
Wild type 149.7 43.4 59.8 19.9 0.40 –
bck2Δ 44.3 3.4 25.3 0.8 0.57 0.43
bub2Δ 71.4 8.4 48.6 3.5 0.68 0.70
cdh1Δ 66.7 5.7 19.6 2.2 0.29 −0.27
cin8Δ 53.7 20.0 37.1 5.0 0.69 0.73
clb1Δ 57.6 5.2 19.2 2.2 0.33 −0.16
clb2Δ 56.3 4.3 20.2 7.8 0.36 −0.10
clb3Δ 77.5 15.1 27.7 3.6 0.36 −0.11
clb4Δ 59.4 4.5 19.3 2.1 0.32 −0.19
clb5Δ 98.0 21.4 33.6 6.5 0.34 −0.14
clb6Δ 76.1 8.6 31.6 2.7 0.42 0.04
cln1Δ 80.1 24.3 20.7 0.6 0.26 −0.35
cln2Δ 82.7 15.8 42.9 3.8 0.52 0.30
cln3Δ 47.0 10.9 22.0 10.8 0.47 0.17
lte1Δ 84.8 20.9 32.0 16.0 0.38 −0.06
mad2Δ 47.4 6.0 35.2 2.9 0.74 0.86
mbp1Δ 21.6 11.4 15.0 2.1 0.69 0.73
mih1Δ 64.4 12.1 29.3 3.7 0.46 0.14
sic1Δ 71.8 20.1 20.2 11.8 0.28 −0.29
swe1Δ 124.4 13.0 42.2 5.3 0.34 −0.15
swi4Δ 76.1 15.1 28.4 6.6 0.37 −0.07
swi5Δ 94.0 23.8 37.3 12.6 0.40 −0.01
swi6Δ 64.0 8.7 35.2 7.2 0.55 0.38
whi5Δ 69.6 15.8 33.8 10.9 0.49 0.22
*Average and SD of four independent experimental trials are shown.
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lower than those in the wild type, indicating that the
lower limits of GFP-TDegFCdc20 increased in these
strains. This implies that the deleted genes are involved
in the production or activation of Cdc20 or have func-
tions overlapping those of Cdc20 (Additional file 1:
Figure S3). In these cases, the genes could be synthetic-
ally lethal with cdc20 mutants or multicopy suppressors
of cdc20 mutants.
Other strains, such as mad2Δ, cin8Δ, and mbp1Δ,
showed positive relative copy number change values, in-
dicating that the copy numbers of the TEV plasmids
were higher than those in the wild type; thus, the lower
limits of GFP-TDegFCdc20 decreased in these strains.
These deleted genes are therefore involved in inhibition
of Cdc20, e.g., by inhibition of Cdc20 production or
Cdc20 activity or degradation of Cdc20 (Additional file
1: Figure S4). These genes could be dosage suppressors
of the toxicity of Cdc20 overexpression.
Previous studies, including systematic analyses, identi-
fied genes showing genetic interactions with CDC20[13,27-30]; these were listed in the Saccharomyces
Genome Database (yeastgenome.org). From these inter-
actions, we summarized relevant genetic interactions
studied here in Table 2 and Figure 4A. Importantly, the
relative copy number of the TEV plasmid decreased in
deletion strains involving genes showing synthetic lethal-
ity or dosage rescue of the cdc20 mutant, whereas the
relative copy number of the TEV plasmid increased in
deletion strains involving genes showing synthetic res-
cue, phenotypic suppression, and dosage lethality of the
cdc20 mutant. This result indicated that our TIPI-
gTOW approach gave information regarding genetic
interactions, which was highly consistent with the previ-
ously identified interactions. Moreover, the advantage of
our approach is that we could isolate genetic interac-
tions in both directions, namely negative interactions
such as synthetic lethal and dosage rescue and positive
interactions such as synthetic rescue, phenotypic sup-
pression, and dosage lethality in a single experiment.
Among genetic interactions obtained in this study, the
difference between CLN1 and CLN2 was surprising
Figure 4 Evaluation of the lower limits of Cdc20 protein on deletion of cell cycle regulators. (A) Relative copy number changes in the
TEV plasmids in gene-deletion strains with GFP-TdegFCDC20. Genes with previously identified genetic interactions with cdc20 mutation were boxed
(summarized in Table 2). The original data used for the graph is shown in Table 1. (B) Relative copy number changes in TEV plasmids in gene-
deletion strains with GFP-TdegFCDC20 selected from A and simulation results. The degradation rate of kd20 is gradually increased until the cell cycle
simulation indicates “dead.” In the simulation, 1: Clb1 and Clb2, 2: Clb5 and Clb6, 3: Cln1 and Cln2, and 4: Cln3 and Bck2 are implemented as
single genes. 5: Swi6 is implemented into the component of SBF (together with Swi4) and MBF (together with Mbp1). The original data used for
the graph is shown in Table 1 and Additional file 1: Table S2.
Table 2 Known genetic interactions with CDC20 mutation listed in the Saccharomyces Genome Database*
Gene Genetic interaction with the cdc20 Mutant Description References
BUB2 Synthetic Rescue Temperature sensitivity of cdc20-1(ts) is rescued by bub2 deletion. [27]
CDH1 Synthetic Lethality cdc20-1(ts) shows synthetic lethality with cdh1 deletion. [28]
CIN8 Dosage Lethality In the absence of CIN8, overexpression of CDC20 is lethal. [29]
CLB2 Negative Genetic Growth defect of cdc20_tsq368 increases with clb2 deletion. [13]
LTE1 Synthetic Lethality cdc20-1(ts) shows synthetic lethality with lte1 deletion. [28]
MAD2 Phenotypic Suppression cdc20 blocks the premature degradation of Pds1 observed in a mad2 mutant. [30]
SIC1 Synthetic Lethality cdc20-1(ts) shows synthetic lethality with sic1 deletion. [28]
*When synonymous genetic interactions were reported in more than one study, one representative is listed.
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tions [31]. Previous analysis, however, showed that CLB4
has opposite genetic interactions with CLN1 and CLN2
[32]. Our results might indicate that these genes have
different functions in some contexts.
Comparison of experimental data with predictions of a
simulation model is useful for evaluating the predictive
ability of the mathematical model and for speculating
about molecular mechanisms generating negative/posi-
tive genetic interactions [7,9,10]. An integrative mathem-
atical model of the budding yeast cell cycle was
developed previously [33], and we have modified this
model using gTOW data [9]. Using the “stabilization
model” published in the reference [9], we here measured
how much the degradation parameter of Cdc20 could be
increased (i.e., the upper limit of kd20) in each of the
gene-deletion models and compared the upper limit of
kd20 with that in the wild type to obtain the relative
change in the upper limit of kd20 (see Methods for de-
tails). This analysis is considered to represent the process
of TIPI-gTOW, namely indirectly assessing the lower
limits of Cdc20 in the presence of gene deletions, by
measuring how much degradation can increase without
halting the cell cycle. The simulation result is shown in
Additional file 1: Table S2. Figure 4B shows the compari-
son of the results of TIPI-gTOW and those of the simula-
tion. Deletion strains, such as mad2Δ, cdh1Δ, and others,
showed good agreements between TIPI-gTOW and simu-
lation data; however, some genes such as sic1Δ, swi5Δ, and
mbp1Δ showed almost opposite changes, suggesting ab-
sence of some regulatory steps in the model.
Conclusions
In this study, we tried to develop a method for estimat-
ing the lower limit of protein expression by combining
the TIPI and gTOW methods. Using TIPI-gTOW, we
successfully constructed a strain in which GFP-TDegF
Ade2 was expressed at the lower limit, just sufficient to
support cellular growth under the −Ade condition by ac-
celerating degradation by TEV protease.
We also succeeded in constructing a strain in which
the minimal level of GFP-TDegFCdc20 was expressed by
TIPI-gTOW. Using this strain, we studied genetic inter-
actions between cell cycle regulators and CDC20. We
concluded that TIPI-gTOW is useful for estimating
changes in the lower limit of a protein under different
conditions, such as different genetic backgrounds and
environments. TIPI-gTOW is useful for analyzing gen-
etic interactions of essential genes whose deletion mu-
tants cannot be obtained. One important characteristic
of TIPI-gTOW is that it is useful for identifying both
negative and positive genetic interactions, as shown in
Figure 4. The synthetic genetic array is a potent high-
throughput approach to identifying genetic interactions[34], which now allows quantitative analyses [35] and
can also applied to essential genes [36]. TIPI-gTOW de-
veloped in this study may be an alternative method to
study genetic interactions in detail.
The conventional gTOW method developed previously
uses a gene with a native promoter and terminator as a
unit to increase protein expression and measures the
copy number limit to estimate the “copy number limit
for protein overexpression” [7,8,10,11]. The advantage of
gTOW is that we can indirectly estimate by how much a
target protein can be overexpressed over the native level
by simply measuring the copy number of the gTOW
plasmid. In TIPI-gTOW, however, we first have to mod-
ify the native copy of the target gene, which changes the
native expression, activity, and stability of the target pro-
tein. In addition, the aim of the procedure is to reduce
the expression of the target protein, which makes it diffi-
cult to quantitate the lower limit of the target protein by
western blotting when this level is under the detection
limit. In fact, we have failed to detect the protein levels
of Ade2 and Cdc20 by western blotting using their spe-
cific antibodies (data not shown). We thus believe that
TIPI-gTOW is a method by which a cellular condition
can be constructed with the target protein expressed at
the lower limit still supporting cellular function. Thus, it
is useful for identifying genetic interactions as described
above, although it does not measure the absolute lower
limit of the target protein.
To use TIPI-gTOW, the optimal expression for the
target GFP-TDegF protein must be determined so that
the level is within the range of detection of the lower
limit by increasing the TEV plasmid. Taxis and Knop de-
veloped a series of TDeg constructs with different pro-
moters and N-degrons of various strengths [23], which
will be useful to systematically determine the optimal
expression.
Previous studies on haploinsufficiency and dosage
compensation suggested that most of yeast proteins are
expressed at least twice more than the levels required in
diploid cells [37,38]. If we could detect the lower limit
protein levels under the TIPI-gTOW experiments, we
might be able to argue about this issue. We failed to de-
tect some proteins using western blotting with specific
antibodies as described above. Fusing the target proteins
with more sensitive proves might be useful.
Methods
Yeast strains and growth conditions
Yeast strains used in this study are listed in Table 3.
A S. cerevisiae strain BY4741 (MATa, his3Δ1, leu2Δ0,
met15Δ0, ura3Δ0) [39] was used as the host strain for
the experiments. BY4741 derivatives with gene deletions
in the cell cycle regulators were obtained from Open
Biosystems/Thermo Scientific. YSM001 was constructed
Table 3 Yeast strains used in this study
Name Genotype Source




















Table 4 Plasmids used in this study
Name Relevant characteristics Source
pSBI40 2 μ ori, URA3, leu2d; plasmid
for gTOW experiment
[7]






pSS1006 P_CUP1-P14*–TEV+ in pSBI40 This study
pSM001 P_CDC19−500 instead of P_CDC19
in pSS1002
This study
pSM002 P_CDC19−600 instead of P_CDC19
in pSS1002
This study
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which was amplified by PCR with the primers OHML432
and OHML389 using pSS1002 as a template, into the
chromosomal ADE2 locus of BY4741. Similarly, YSM002
was constructed by integrating the P_CDC19−500-
GFP-TDegF fragment, which was amplified by PCR with the
primers OHML504 and OHML505 using pSM001 as
a template, into the chromosomal CDC15 locus of
BY4741. YSM003 was constructed by integrating the
P_CDC19−500-GFP-
TDegF fragment, which was amplified
by PCR with the primers OHML506 and OHML507 using
pSM001 as a template, into the chromosomal CDC20
locus of BY4741. YSM004 was constructed by integrating
the P_CDC19−500-GFP-
TDegF fragment, amplified by PCR
using the primers OHML508 and OHML509 and
pSM001 as a template, into the chromosomal CDC28
locus of BY4741. YSM005 was constructed as for
YSM004, except that pSM002 was used as a PCR tem-
plate. Each P_CDC19−500-GFP-
TDegFCDC20 integrated
strain harboring a gene deletion was constructed by inte-
grating the same DNA fragment as YSM003 into the
chromosomal CDC20 locus of each deletion strain. The
sequences of PCR primers are listed in Additional file 1:
Table S3. Yeast cells were cultured as described previously
[9,40]. Yeast cells were cultured in SC media without ura-
cil (Ura), adenine (Ade), leucine (Leu), and histidine (His)
as indicated. 2% glucose was used as a carbon source. SC
media were made using YNB with ammonium sulfate (MP
biomedicals) that contains 0.25 μM Cu2+.
Plasmids used in this study
Plasmids used in this study are listed in Table 4. pSS1006
(the TEV plasmid) was constructed by inserting p14*–
TEV+ from pDS5 [22] into pSBI40 [7] so that p14*–TEV+
is expressed under control of the CUP1 promoter. pSS1002
was constructed by connecting hph-MX4, a hygromycin
B-resistance cassette [41], the CDC19 promoter, GFP-
TDegF from pDS41 [22], and ADE2, followed by insertion
into pRS423ks [11]. pSS1002, with different lengths of
CDC19 promoters, was constructed using the PCR primersOHML541–547 and OHML540; the sequences are listed in
Additional file 1: Table S3.Copy number determination of plasmids
The copy number of a plasmid in a cell was measured as
described previously [7] with some modifications. Cells
of each yeast strain with pSS1006 (the TEV plasmid) or
pSBI40 (the empty vector plasmid) were grown for 50 h
in 200 μL SC medium without relevant amino acids.
The cells were corrected and suspended into 50 μL of
Zymolyase solution (10 mM Na-phosphate [pH 7.5],
1.2 M sorbitol, and 2.5 mg/ml Zymolyase 100 T (Nacalai
tesque)). The cell suspension was incubated for 15 min
at 37°C, and then incubated for 10 min at 100°C. After
removing the cell debris by centrifugation, the supernatant
was used as the total DNA solution. Two real-time PCRs
were performed using 2 μL of the DNA solution as tem-
plates with LEU2 and LEU3 primer sets (primer sequences
are listed in Additional file 1: Table S3), using LightCycler®
480 SYBR Green I Master with the LightCycler® 480
system (Roche). The LEU2 and LEU3 primer sets were
used to quantify the LEU2 DNA from the plasmid
and the LEU3 DNA from the genome, respectively.
The plasmid copy number per haploid genome was
estimated by comparing the relative amount of the LEU2
DNA and the LEU3 DNA as follows: Plasmid copy
number ¼ 2 CpLEU2−CpLEU3ð Þ , where Cp_LEU2 and Cp_LEU3
are the crossing points of PCR amplifications using the
LEU2 and LEU3 primer sets, respectively.
The relative copy number change of the TEV
plasmid was calculated as follows: Relative copy num-
ber change = (ΔCT/CV −wtCT/wtCV)/(wtCT/wtCV), where
ΔCT is the average copy number of the TEV plasmid in
each knockout strain, ΔCV is the average copy number
of the empty vector plasmid in each knockout strain,
wtCT is the average copy number of the TEV plasmid
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number of the empty vector plasmid in the wild-type
strain.
Western blotting
Cells were cultivated in SC medium, and the proteins
were extracted as described previously [7]. The proteins
were separated using NuPAGE® 4-12% Bis-Tris gels,
and transferred them onto a PVDF membrane using
iBlot® gel transfer system (Life Technologies), then the
target proteins were detected using their specific anti-
bodies. For the detection of GFP, TEV protease, and
Cdc28, antibodies 1814460 (Roche), PAB19931
(Abnova), and sc-6709 (Santa Cruz Biotechnology) were
used, respectively. For the second antibodies, Histofine®
simple stain MAX PO (MULTI) and Histofine® simple
stain MAX PO (G)(Nichirei) were used. Coomassie®
G-250 (SimplyBlue™ SafeStain, Life Technologies) was
used to stain loading controls.
Computation
Numerical simulations were performed using Matlab
version 7.3.0 with the “stabilization model” described
previously [9]. The rate of degradation of kd20 was grad-
ually increased until the cell cycle simulation yielded the
result “dead.” The relative degradation rate change was
calculated as follows: Relative degradation rate change =
(ΔULkd20 −wtULkd20)/wtULkd20, where ΔULkd20 is the
upper limit of kd20 in a deletion mutant model and
wtULkd20 is that in the wild-type model.
Additional file
Additional file 1: This file contains 3 tables (Table S1. Summary of
construction of GFP-DegF integrated strains with different lengths of
CDC19 promoters. Table S2. Upper limits of the rates of degradation of
Cdc20 (kd20) in gene-deletion models. Table S3. PCR primers used in
this study.) and 4 figures (Figure S1. Serial deletions of the CDC19
promoter. Figure S2. Correlation between the copy numbers of vector
and TEV plasmids. Figure S3. Potential outcomes of TIPI-gTOW of Cdc20
in cell cycle regulator deletion strains and their regulatory interactions
(Case 1). Figure S4. Potential outcomes of TIPI-gTOW of Cdc20 in cell
cycle regulator deletion strains and their regulatory interactions (Case 2)).
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